PELI1 and rectum adenocarcinoma: Pathological stage progression correlated with increasing PELI1 expression in LIHC, KIRC, CHOL, ESCA, and STAD, but decreasing levels in breast invasive carcinoma (BRCA), kidney chromophobe (KICH), rectal adenocarcinoma (READ), and UCEC (Figure 1C).